Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Interest & Investment Income (2022 - 2025)

Historic Interest & Investment Income for Exagen (XGN) over the last 4 years, with Q3 2025 value amounting to $3000.0.

  • Exagen's Interest & Investment Income fell 9847.72% to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $443000.0, marking a year-over-year decrease of 4037.69%. This contributed to the annual value of $767000.0 for FY2024, which is 4940.63% down from last year.
  • Latest data reveals that Exagen reported Interest & Investment Income of $3000.0 as of Q3 2025, which was down 9847.72% from $85000.0 recorded in Q2 2025.
  • Exagen's 5-year Interest & Investment Income high stood at $656000.0 for Q1 2023, and its period low was $3000.0 during Q3 2025.
  • Its 4-year average for Interest & Investment Income is $211166.7, with a median of $186500.0 in 2024.
  • In the last 5 years, Exagen's Interest & Investment Income soared by 1302000.0% in 2023 and then plummeted by 9847.72% in 2025.
  • Quarter analysis of 4 years shows Exagen's Interest & Investment Income stood at $5000.0 in 2022, then soared by 3360.0% to $173000.0 in 2023, then grew by 13.87% to $197000.0 in 2024, then plummeted by 98.48% to $3000.0 in 2025.
  • Its Interest & Investment Income was $3000.0 in Q3 2025, compared to $85000.0 in Q2 2025 and $158000.0 in Q1 2025.